AMENDMENT AND CLARIFICATION TO 1/11/2018 RELEASE : ENTRY INTO CANNABIS TECH SECTOR CALIPHARMS 2018 GROWTH STRATEGY

Riverside, CA -- February 13, 2018 -- InvestorsHub NewsWire -- CaliPharms, Inc. (OTCPink: KGET), a Development Stage Company operating in the California Medicinal Cannabis Industry, publicly trading under the OTC Markets symbol "KGET" releases its growth plans for 2018.

CaliPharms has expanded its acquisition model into the Cannabis Tech Sector with a medical cannabis delivery app. The Company has already met three times with a cannabis delivery blockchain app developer that could expand the CaliPharms business model into the cannabis tech sector.

According to the app developer in laymen's terms; the App was developed to deliver Cannabis and Cannabis related products to legal use home users with a similar type of customer coordination as the Uber App. The App would not physically touch the product, but it would connect customers to drivers and bill the customers using the block-chain internal software. Essentially the system could allow customers to pay by credit card and have the products delivered to their home. An internal cryptocurrency would be used to complete each transaction. The company would have to hold actual Government Currency within its account to bridge each transaction from delivery to doorstep.

CaliPharms President Bo Linton stated, “We continue our meetings with potential acquisition candidates within the Cannabis Industry. So far this year we have already had very promising meetings with companies to discuss acquisition roll ups in the following; Cannabis Delivery Blockchain App, Extraction Oils, Vape Pens, Vape Cartridges, and Cannabis farms within the State of California.”

Linton continued, “I was hesitant to put out a press releases using the word “Block-chain” as the SEC has stated the following in a recent Bloomberg article. https://www.bloomberg.com/news/articles/2018-01-31/signaling-crackdown-sec-boss-emerges-as-crypto-skeptic-in-chief. However; it would be unfair to not disclose to our shareholders the progress and business models we are actively pursuing. The blockchain application we are working to acquire has been described to the Company as a medical cannabis delivery application which uses the blockchain for billing purposes. Until we sign an official agreement and hire an expert in blockchain code as a Chief Technical Officer, I recommend investors use extreme caution when considering an investment into CaliPharms if that decision is based solely on the block-chain or cryptocurrency investment frenzy currently taking place. CaliPharms has no intentions to raise money in an Initial Coin Offering, (ICO) at this time. CaliPharms would ONLY explore the ICO at such time the SEC has determined it as a valid and SEC regulated investment.”

Please see our company videos

Company Vision https://youtu.be/UNjImyPw1Oc

Business Vision https://youtu.be/TCTrG_EC4VU

For up to date information on the company please follow us @

facebook.com/CaliPharms

twitter.com/CaliPharms

About CaliPharms, Inc.

CaliPharms Inc., trading under the symbol (KGET) which trades under its former name Kleangas Energy Technologies, Inc. is a development stage medical marijuana-cannabis business. The Company currently is focused within the medical marijuana-cannabis industry. The company intends to expand into other sectors that support the legalized cannabis industry as the laws for each individual State and the Federal Government change and allow.

Safe harbor from liability established by the Private Securities Litigation Reform Act of 1995. These forward-looking statements generally can be identified by phrases such as CaliPharms or KGET or its management "believes," "expects," "anticipates," "foresees," "forecasts," "estimates" or other words or phrases of similar import. Similarly, statements herein that describe the Company's business strategy, outlook, objectives, plans, intentions or goals also are forward-looking statements. All such forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those in forward-looking statements. Investment into a microcap company is a high risk investment and it should only be considered if you are able to afford a total loss of the investment. Laws and Regulations of Marijuana are currently in direct contradiction between California and Federal Law and these factors should be a part of your consideration when making an investment into KGET.

Company Contact:

CaliPharms, Inc. (KGET)

www.CaliPharmsInc.com

facebook.com/CaliPharms

twitter.com/CaliPharms

Telephone 1-949-800-6645

Email: info@CaliPharmsInc.com

Kleangas Energy Technolo... (CE) (USOTC:KGET)
Historical Stock Chart
From Oct 2024 to Nov 2024